(Press-News.org) About The Study: Among patients with heart failure with mildly reduced ejection fraction/heart failure with preserved ejection fraction in the Finerenone Trial to Investigate Efficacy and Safety Superior to Placebo in Patients With Heart Failure randomized clinical trial, higher proportions of cardiovascular and overall mortality in those with ejection fraction less than 50% were related principally to higher proportions of sudden death. A clear treatment effect of finerenone on cardiovascular or cause-specific mortality was not identified, although the trial was likely underpowered for these outcomes.
Corresponding Author: To contact the corresponding author, Akshay S. Desai, MD MPH, email adesai@bwh.harvard.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamacardio.2025.0860)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.
# # #
Media advisory: This study is being presented at the American College of Cardiology’s Annual Scientific Session.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2025.0860?guestAccessKey=f36c1246-8497-426e-8e67-6a1321a10320&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=033025
END
Mode of death in patients with heart failure with mildly reduced or preserved ejection fraction
JAMA Cardiology
2025-03-30
ELSE PRESS RELEASES FROM THIS DATE:
Intravenous ferric carboxymaltose in heart failure with iron deficiency
2025-03-30
About The Study: In patients with heart failure and iron deficiency, ferric carboxymaltose did not significantly reduce the time to first heart failure hospitalization or cardiovascular death in the overall cohort or in patients with a transferrin saturation less than 20%, or reduce the total number of heart failure hospitalizations vs placebo.
Corresponding Author: To contact the corresponding author, Stefan D. Anker, MD, PhD, email s.anker@cachexia.de.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2025.3833)
Editor’s ...
Artificial intelligence in the prevention of sudden death
2025-03-30
Many cases of sudden cardiac death could be avoided thanks to artificial intelligence. As part of a new study to be published in European Heart Journal, a network of artificial neurons imitating the human brain was developed by researchers from Inserm, Paris Cité University and the Paris public hospitals group (AP-HP), in collaboration with their colleagues in the USA. During the analysis of data from over 240 000 ambulatory electrocardiograms, this algorithm identified patients at risk of a serious arrhythmia that was capable of triggering cardiac arrest within the following 2 weeks in over 70% of cases.
Each ...
Oral semaglutide vastly reduces heart attacks, strokes in people with type 2 diabetes
2025-03-29
Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention for their effectiveness against weight gain, high blood sugar, and even alcohol cravings.
A new clinical trial, co-led by endocrinologist and diabetes expert John Buse, MD, PhD, and interventional cardiologist Matthew Cavender, MD, MPH, at the UNC School of Medicine has shown that the oral form of semaglutide can significantly reduce cardiovascular events in people with type 2 diabetes, atherosclerotic cardiovascular disease, and/or ...
Prothrombin complex concentrate vs frozen plasma for coagulopathic bleeding in cardiac surgery
2025-03-29
About The Study: In this unblinded randomized clinical trial, prothrombin complex concentrate had superior hemostatic efficacy and safety advantages to frozen plasma among patients requiring coagulation factor replacement for bleeding during cardiac surgery.
Corresponding Author: To contact the corresponding author, Keyvan Karkouti, MD, email keyvan.karkouti@uhn.ca.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2025.3501)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, ...
Who needs a statin? New study compares prescribing recommendations based on traditional risk factors vs. coronary artery calcium scoring
2025-03-29
A new study by researchers at Intermountain Health in Salt Lake City aims to determine the best method to screen and evaluate patients who are at risk of developing coronary heart disease and which patients would benefit from taking a statin medication to lower cholesterol.
Currently, cardiologists determine a patient’s need for a statin based on traditional risk factors, using the Pooled Cohort Equation (PCE), which calculates coronary risk by assessing the risk factors of age, sex, total and HDL cholesterol levels, blood pressure, and whether someone ...
Finerenone and atrial fibrillation in heart failure
2025-03-29
About The Study: The efficacy of finerenone was consistent regardless of atrial fibrillation status in this study. New-onset atrial fibrillation was associated with a substantially higher risk of subsequent outcomes.
Corresponding Author: To contact the corresponding author, John J. V. McMurray, MD, email john.mcmurray@glasgow.ac.uk.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamacardio.2025.0848)
Editor’s Note: Please see the article for additional information, including other authors, ...
Low coronary artery calcium score is associated with an excellent prognosis regardless of a person’s age, new study finds
2025-03-29
Having a coronary artery calcium (CAC) score of zero has generally been accepted as a marker of a very low risk of having a cardiac event within the next five years. However, age is a strong contributor to coronary risk, with risk increasing markedly as people age.
Whether age-related risk factors diminish the low risk predicted by a zero coronary artery calcium score has been uncertain – until now.
A large new study of more than 40,000 patients from heart researchers at Intermountain Health in Salt Lake City finds that a zero coronary artery calcium score continues to be an accurate indicator of a low risk for a coronary ...
Groundbreaking consensus statement on conduction system pacing released: a major milestone in the evolution of pacing therapy
2025-03-29
Vienna, 30 March 2025– The European Society of Cardiology (ESC) has released a groundbreaking consensus statement on conduction system pacing (CSP), marking a significant milestone in the evolution of pacing therapy. The document was officially presented today at the EHRA 2025 congress in Vienna and simultaneously published in EP Europace.
For over 50 years, right ventricular pacing has been a standard treatment for slow heart rhythms. However, in some patients, this approach can lead to reduced heart function and even heart failure. Furthermore, biventricular pacing ...
Nuclear monitoring system suggests landslide cut off internet in west Africa
2025-03-29
Hydroacoustic signals captured by the world’s international nuclear monitoring system suggest an underwater landslide may have broken communications cables and disrupted internet traffic in west African countries for several weeks in March 2024.
Researchers used data collected by hydrophones installed by the International Monitoring System of the Comprehensive Nuclear-Test-Ban Treaty Organization (CTBTO) to determine the location of the possible landslide, placing it along the steep slopes of Trou Sans Fond Canyon offshore of Ivory Coast.
The proposed landslide corresponds with the timing and location of four broken cables in the canyon, according to Vaibhav Vijay Ingale of UC ...
PNNL scientist elected AAAS fellow
2025-03-29
RICHLAND, Wash.—Chemist Zheming Wang, whose research largely focuses on the chemistry underlying radioactive and advanced energy materials, as well as critical elements, has been elected as a Fellow of the American Association for the Advancement of Science—the highest honor the society bestows. AAAS is the world's largest multidisciplinary scientific society with a mission to “advance science, engineering, and innovation throughout the world for the benefit of all people.”
AAAS notes that Fellows are celebrated for contributions that span ...
LAST 30 PRESS RELEASES:
Omega-6 fatty acid promotes the growth of an aggressive type of breast cancer
FAU secures $1.3 million NIH grant for breakthrough in HIV self-test technology
Study finds higher cardiac deaths in combined day-night heatwaves
NYC, Baltimore research scientists receive grants to study cardiovascular/diabetes connection
AI propaganda: prolific and persuasive
An efficient self-assembly process for advanced self-healing materials
Study reveals stark racial disparities in IBD care across the united states
Break the sedentary cycle: National Walking Day can kickstart healthier routines
Researchers develop new way to match young cancer patients with the right drugs
New 3D technology paves way for next-generation eye-tracking
Diagnosing a dud may lead to a better battery
We know nanoplastics are a threat—this new tool can help us figure out just how bad they are
Mpox could become a serious global threat, scientists warn
Combination immunotherapy shrank a variety of metastatic gastrointestinal cancers
Newborn warty birch caterpillars defend the world’s smallest territory
Exposure to air pollution in childhood is associated with reduced brain connectivity
Researchers develop test using machine learning to help predict immunotherapy response in lymphoma patients
New UNSW research reveals dramatically higher loss of GDP under 4°C warming
Discovery of Quina technology challenges view of ancient human development in East Asia
Whales and dolphins sleep by turning off one half of their brains at a time; scientists discover more about the genes and pathways that enable this phenomenon
A new clue to how multicellular life may have evolved
ALL ALS consortium launches website to advance ALS research
Many TB cases may have gone undetected in prisons in Europe and the Americas during COVID-19
Predicting older people’s frailty helps doctors intervene earlier
New study validates lower limits of human heat tolerance
UTA takes lead with mobile lab to address rural health care crisis
New flexible hydrogel could improve drug delivery for post-traumatic osteoarthritis treatment
Association for Molecular Pathology celebrates U.S. District Court’s decision to vacate FDA rule on laboratory-developed test procedure regulation
Dr. Christopher Kramer is new American College of Cardiology President
Dr. David Winchester is new Chair of ACC Board of Governors
[Press-News.org] Mode of death in patients with heart failure with mildly reduced or preserved ejection fractionJAMA Cardiology